Abstract:The E3 ubiquitin ligase MDM2 functions as a crucial negative regulator of the p53 tumor suppressor protein by antagonizing p53 transactivation activity and targeting p53 for degradation. Cellular stress activates p53 by alleviating MDM2-mediated functional inhibition, even though the molecular mechanisms of stress-induced p53 activation still remain poorly understood. Two opposing models have been proposed to describe the functional and structural role in p53 activation of Ser17 phosphorylation in the N-terminal "lid" (residues 1-24) of MDM2. Using the native chemical ligation technique, we synthesized the p53-binding domain (1-109)MDM2 and its Ser17-phosphorylated analogue (1-109)MDM2 pS17 as well as (1-109)MDM2 S17D and (25-109)MDM2, and comparatively characterized their interactions with a panel of p53-derived peptide ligands using surface plasmon resonance, fluorescence polarization, and NMR and CD spectroscopic techniques. We found that the lid is partially structured in apo-MDM2 and occludes p53 peptide binding in a ligand size-dependent manner. Binding of (1-109)MDM2 by the (15-29)p53 peptide fully displaces the lid and renders it completely disordered in the peptide-protein complex. Importantly, neither Ser17 phosphorylation nor the phospho-mimetic mutation S17D has any functional impact on p53 peptide binding to MDM2. Although Ser17 phosphorylation or its mutation to Asp contributes marginally to the stability of the lid conformation in apo-MDM2, neither modification stabilizes apo-MDM2 globally or the displaced lid locally. Our findings demonstrate that Ser17 phosphorylation is functionally neutral with respect to p53 binding, suggesting that MDM2 phosphorylation at a single site is unlikely to play a dominant role in stress-induced p53 activation.

Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction

Mutant p53 sequestration of MDM2 acidic domain inhibits E3 ligase activity.

MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Complex Structures of Human MDM2 with Interacting Proteins Reveal the Regulation Mechanism of P53

Interrogation of MDM2 Phosphorylation in P53 Activation Using Native Chemical Ligation: the Functional Role of Ser17 Phosphorylation in MDM2 Reexamined

Acidic Domain is Indispensable for MDM2 to Negatively Regulate the Acetylation of P53

P300/mdm2 Complexes Participate in MDM2-mediated P53 Degradation.

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

Regulation of MDM2 Stability After DNA Damage

Mdm2 Inhibits Axin-Induced P53 Activation Independently Of Its E3 Ligase Activity

A Function for the RING Finger Domain in the Allosteric Control of MDM2 Conformation and Activity*

Structure of Human Mdm2 Complexed with Rpl11 Reveals the Molecular Basis of P53 Activation

Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination.

Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function

Regulation of the Mdm2–p53 Pathway by the Ubiquitin E3 Ligase MARCH 7

Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Secondary Interaction Between MDMX and P53 Core Domain Inhibits P53 DNA Binding.

Characterization of cancer-associated missense mutations in MDM2

Small Molecule Inhibitors of the P53-Mdm2

Acetylation Of P53 Inhibits Its Ubiquitination By Mdm2